Lv11
74 积分 2023-03-06 加入
MG-K10, a Long-Acting Anti-IL-4 Receptor Alpha Monoclonal Antibody in Adult Patients with Moderate-to-Severe Atopic Dermatitis
4小时前
已关闭
Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches
5个月前
已完结
Unresectable stage III non-small-cell lung cancer: state of the art and challenges
5个月前
已关闭
Unresectable stage III non-small-cell lung cancer: state of the art and challenges
5个月前
已完结
Immune-checkpoint inhibition for resectable non-small-cell lung cancer — opportunities and challenges
5个月前
已完结
Targeting HER2 in lung cancers: Evolving treatment landscape and drug development strategies
6个月前
已完结
Zongertinib in Previously Treated HER2 -Mutant Non–Small-Cell Lung Cancer
6个月前
已完结
Impact of HER2 expression on EGFR-TKI treatment outcomes in lung tumors harboring EGFR mutations: A HER2-CS study subset analysis
6个月前
已完结
Targeting Lung Cancer with Precision: The ADC Therapeutic Revolution
7个月前
已完结
Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial
8个月前
已完结
皖公网安备34019202002308
